BMP signaling has a crucial role in skin development and homeostasis, whereas molecular mechanisms underlying its involvement in regulating gene expression programs in keratinocytes and fibroblasts remain largely unknown. We show here that several BMP ligands, all BMP receptors, and BMP-associated Smad1/5/8 are expressed in human primary epidermal keratinocytes and dermal fibroblasts. Treatment of both cell types by BMP-4 resulted in the activation of the BMP-Smad, but not BMP-MAPK pathways. Global microarray analysis revealed that BMP-4 treatment induces distinct and cell type-specific changes in gene expression programs in keratinocytes and fibroblasts, which are far more complex than the effects of BMPs on cell proliferation/ differentiation described earlier. Furthermore, our data suggest that the potential modulation of cell adhesion, extracellular matrix remodeling, motility, metabolism, signaling, and transcription by BMP-4 in keratinocytes and fibroblasts is likely to be achieved by the distinct and cell-type-specific sets of molecules. Thus, these data provide an important basis for delineating mechanisms that underlie the distinct effects of the BMP pathway on different cell populations in the skin, and will be helpful in further establishing molecular signaling networks regulating skin homeostasis in health and disease.
INTRODUCTION
Bone morphogenetic protein (BMP) signaling has important roles in regulating multiple functions in developing and postnatal skin, including the control of cellular proliferation and differentiation, epithelial-mesenchymal interactions, melanogenic activity and tissue remodeling (reviewed in (Botchkarev, 2003) ). BMPs are also involved in controlling the variety of pathobiological processes in the skin, including wound healing, psoriasis, and carcinogenesis (Blessing et al., 1995 (Blessing et al., , 1996 Kaiser et al., 1998) Data obtained during the last decade revealed that BMP signaling is capable of modulating the activity of major cellular components of the skin including epidermal and hair follicle keratinocytes, dermal fibroblasts, melanocytes, and epithelial stem cells (D'Souza et al., 2001a; Park and Morasso, 2002; Kobielak et al., 2003 Kobielak et al., , 2007 Sharov et al., 2003 Sharov et al., , 2005 Andl et al., 2004; Plikus et al., 2004; Zhang et al., 2006) . However, despite its broad involvement in the control of skin homeostasis and remodeling, the mechanisms of regulation and transcriptional targets for BMP signaling in distinct skin cell populations remain to be elucidated.
BMPs belong to the transforming growth factor-b (TGF-b) superfamily and bind to the transmembrane receptor complex formed by the type I (ActR-I/Alk-2, BMPR-IA/Alk-3, BMPR-IB/ Alk-6) and type II (BMPR-II, ActR-IIA, ActR-IIB) receptors (Miyazono et al., 2005; Kitisin et al., 2007) . Ligand binding to the BMP receptor complex results in phosphorylation of the intracellular domain of the type I receptor by the type II receptor kinase domain and leads to transmission of a signal through the BMP-Smad and/or BMP-MAPK pathways (Miyazono et al., 2005; Kitisin et al., 2007) . BMP-specific Smad proteins (Smad1/5/8 or receptor-activated Smads, R-Smads) after phosphorylation form a heteromeric complex with Smad4 (or common partner Smad, Co-Smad) and translocate to the nucleus to regulate the transcription of the BMP-responsive genes. The BMP-MAPK pathway could also use several key MAP kinases (p38, JNK, and/or Erk1/2) (Nohe et al., 2004) , whereas the mechanisms and biological effects of this pathway in cells are much less understood.
Epidermal keratinocytes and dermal fibroblasts are major cellular components of the skin, and their interactions are critical for the proper control of skin development and postnatal homeostasis (Fuchs, 2007) . BMP signaling serves as a powerful regulator of epithelial-mesenchymal interactions in developing skin and is also capable of modulating the functional activity of keratinocytes and fibroblasts postnatally (Botchkarev, 2003; Botchkarev and Kishimoto, 2003) . Moreover, the effects of BMPs on cellular targets strongly depend on the levels and activity of extracellular BMP antagonists, including Noggin that inhibits ligand binding to the BMP receptor complex, and modulate a magnitude of BMP signaling (Balemans and Van Hul, 2002) .
Data obtained from cultured mouse keratinocytes show that cell infection with BMP-6-expressing adenovirus (Drozdoff et al., 1994) or its treatment with recombinant BMP-2 or BMP-6 proteins under distinct culture conditions led to the induction of keratinocyte differentiation (McDonnell et al., 2001; D'Souza et al., 2001b; Park and Morasso, 2002) Thus, in differentiating mouse epidermal keratinocytes, BMP6stimulated keratin 1 and involucrin expression through the BMP-Smad pathway (McDonnell et al., 2001; D'Souza et al., 2001b) , and BMP2 activated the expression of the Dlx-3 transcription factor (Park and Morasso, 2002) . However, stimulatory effects of BMP-2/6 on the differentiation process in human epidermal keratinocytes are seen only in the absence of EGF in culture medium as EGF purportedly exerts an inhibitory effect on the BMP pathway (Gosselet et al., 2007) .
Data obtained from BMP-6 transgenic mice (promoter: keratin 10) show that high levels of BMP-6 in the epidermis inhibit epidermal proliferation, whereas a moderate level of the transgene expression stimulated epidermal proliferation, indicating that the biological effect of BMP signaling depends on the intensity of the signal (Blessing et al., 1996) . This is consistent with the data obtained from Noggin transgenic mice (promoter: keratin 5) that show increased epidermal proliferation and decreased expression of keratinocyte differentiation markers (Sharov et al., 2003) .
In contrast to keratinocytes, the effects of BMP signaling on dermal fibroblasts are only poorly understood. BMP-2 treatment of human dermal fibroblasts in 3D culture leads to their chondrogenic differentiation (Zhou et al., 2004) . Noggin overexpression in the epidermal keratinocytes is accompanied by a thickening of the dermis, suggesting the effects of the BMPs on fibroblast collagen-producing activity (Sharov et al., 2003) . Constitutive deletion of Noggin in mice is accompanied by an increase of p75 kDa neurotrophin receptor expression in the population of dermal fibroblasts that form the follicular papilla (Botchkarev et al., 1999) , in which BMP signaling is important for the maintenance of hair-inductive properties (Rendl et al., 2008) .
Global microarray data reveal that BMP signaling is involved in regulating the expression of over 500 genes in distinct cell types outside of the skin (Locklin et al., 2001; Vaes et al., 2002; Balint et al., 2003; Korchynskyi et al., 2003; Miyoshi et al., 2008) . However, the complex effects of BMP signaling on epidermal keratinocytes and dermal fibroblasts remain unknown. By using global microarray analysis, we show here that BMP signaling causes distinct and cell-type-specific changes in gene expression programs in human primary epidermal keratinocytes and dermal fibroblasts, thus suggesting its involvement in the complex regulation of cell adhesion, extracellular matrix remodeling, cellular motility, metabolism, signaling, and transcription in both cell types.
RESULTS AND DISCUSSION
Components of the BMP-signaling pathway are expressed in human keratinocytes and fibroblasts First, we analyzed the expression of the transcripts for distinct components of the BMP signaling pathway in primary human epidermal keratinocytes and dermal fibroblasts. Under normal culture conditions, both cell types expressed all subtypes of the BMP and activin receptors (BMPR-IA/ Alk-3, BMPR-IB/Alk-6, BMPR-II, ActR-I/Alk-2, ActR-IIA, and ActR-IIB), as well as at least several BMP receptor ligands including BMP-2/4/6 ( Figure 1 ). These results were consistent with data published earlier (Hwang et al., 2001) and suggested that human epidermal keratinocytes and dermal fibroblasts serve as sources and targets of BMP signaling.
BMP-4 treatment leads to activation of the BMP-Smad pathway in human epidermal keratinocytes and dermal fibroblasts
Ligand binding to the BMP receptor complex results in activation of signaling through the SMAD and/or MAP kinase pathways depending on the cell type and conditions (Miyazono et al., 2005) . Binding of the BMP ligands to preformed type I and type II receptor heteromeric complexes leads to activation of SMAD signaling, whereas ligand binding to homomeric type I or type II receptor followed by the formation of a heteromeric receptor complex is likely to result in the activation of the BMP-MAPK pathway (Nohe et al., 2002 (Nohe et al., , 2004 . Treatment of keratinocytes and fibroblasts with BMP-4 for a different duration of time resulted in an increase in Smad1/5/8 phosphorylation in both cell types ( Figure 2 ).
As shown in Figure 2 , cultured keratinocytes and fibroblasts showed differential profiles of constitutive activity of the three MAP kinases (p38, Erk1/2, and JNK) under basal unstimulated conditions. Despite differences in the endogenous levels of phospho-MAP kinases between keratinocytes and fibroblasts, BMP-4 treatment did not cause any significant alterations in their constitutive phosphorylation levels in either cell type ( Figure 2 ), as well as in the levels of the corresponding total proteins (data not shown). MAP kinase pathways are activated by a number of growth factors including the components of EGF and TGF-b signaling (Eckert et al., 2002) . Interactions between the BMP and MAPK pathways are complex, and the active MAPK pathway is capable of inhibiting BMP-Smad signaling through the phosphorylation of the linker region of R-SMADs, prevention of their interaction with SMAD4, and translocation into the nucleus (Kretzschmar et al., 1997) . Our data showed that despite constitutive MAPK signaling, BMP-4 treatment of epidermal keratinocytes and dermal fibroblasts activated the BMP-Smad pathway in both cell types (Figure 2 ). www.jidonline.org 399 MY Fessing et al.
BMP-4 treatment differentially affects gene expression programs in human epidermal keratinocytes and dermal fibroblasts
To define changes in gene expression programs triggered by the BMP-4 treatment in human epidermal keratinocytes and dermal fibroblasts, RNA samples were processed for global microarray analysis using the Affymetrix Human Genome platform, as described previously (Mammucari et al., 2005) .
RNA was isolated from cells treated with recombinant BMP-4 or vehicle control for 8 hours to reveal genes that form the early and intermediate responses to BMP-4 stimulation. The microarray data have been deposited in NCBI's Gene Expression Omnibus (Edgar et al., 2002) and are accessible through GEO Series accession number GSE16111. Gene expression was considered significantly altered if changes in the normalized hybridization signal were 1.8 fold or greater than those in the corresponding controls. Alterations in the expression levels of selected genes were confirmed by quantitative RT-PCR, and the RT-PCR results were generally consistent with the data of microarray analysis (Figure 3a-c) .
Microarray analysis showed that, after BMP-4 treatment, the expression of only 17 genes showed similar changes in the expression levels of both keratinocytes and fibroblasts ( Supplementary Table 1 ). This group of genes included wellknown BMP targets (Miyazono et al., 2005) , such as inhibitors of DNA-binding (ID1/2/3/4), components of the BMP pathway (SMAD6/7) and DLX2 transcription factor (Figure 3a and Supplementary Table 1 ). In addition, several other genes including tropomyosin 1-a were upregulated in both keratinocytes and fibroblasts after BMP-4 treatment ( Supplementary Table 1 ). However, expression of the vast majority of genes showed cell-type-specific dynamics after BMP-4 treatment and was changed only in one cell type whereas remaining unaltered in the other cell type (keratinocytes, 166 genes, fibroblasts, 229 genes, respectively; Supplementary Tables 2 and 3 ). Large numbers of these genes were expressed at comparable levels in both cell types, whereas a certain portion of genes (about 39% in keratinocytes and about 22% in fibroblasts) whose expression was altered by BMP-4 in one cell type showed only very low expression levels in the other cell type ( Supplementary Tables 2 and 3 ). This observation suggested that the differential effects of BMP signaling on gene expression in distinct cell types may depend on a number of mechanisms, including those controlling the basal expression levels of the BMP target genes.
Genes whose expression was changed after BMP-4 treatment in a cell-type-specific manner belonged to distinct functional classes including those encoding cell adhesion/ extracellular matrix proteins, metabolic and proteolytic enzymes, components of the cytoskeleton, and molecules involved in cellular signaling and transcription (Figure 3d -f, Supplementary Tables 2, 3) . These results showed the complex effects of BMP-4 on gene expression programs in both keratinocytes and fibroblasts, which are consistent with earlier observations showing similar effects of BMPs on other cell types (Locklin et al., 2001; Vaes et al., 2002; Balint et al., 2003; Korchynskyi et al., 2003; Miyoshi et al., 2008) . However, our data suggested that a modulation of gene expression programs by BMP-4 in keratinocytes and fibroblasts is achieved by recruitment of distinct sets of molecules, which appears to be specific for each cell type.
Interestingly, BMP-4 treatment did not cause changes of proliferative activity in either keratinocytes or fibroblasts, nor did it alter the expression of cyclin-dependent kinase inhibitors, such as p21 Cip1 and p27 Kip1 , described previously as TGF-b/BMP targets that promote cell differentiation (Pardali et al., 2005; Sharov et al., 2006 ) (data not shown). Under our culture conditions, BMP-4 treatment of primary keratinocytes did not affect the expression of differentiation markers, such as involucrin, loricrin, or suprabasal keratins (data not shown). We assume that the presence of other growth modulators, that is, EGF in culture media, may affect the BMP-4 capacity to significantly influence proliferation/ differentiation in our models.
Indeed, this hypothesis is consistent with the data published earlier and shows a lack of the effects of BMP-2/6 on the differentiation process of primary epidermal keratinocytes in the presence of EGF in the culture medium (Gosselet et al., 2007) . It has been proposed that EGF prevents BMP-mediated keratinocyte differentiation by inhibiting BMP signaling (Gosselet et al., 2007) . It is noted that our data showed that EGF presence in the culture medium did not preclude BMP signaling through SMAD1/5/8 phosphorylation in either cell type. Yet, our results do not rule out the possibility that the EGF-mediated constitutive activity of MAP kinases may exert a negative impact on BMP/SMAD signaling as reported recently (Gosselet et al., 2007) .
Interestingly, BMP-4 treatment of primary keratinocytes resulted in a marked downregulation of expression of thrombospondin 2 (Supplementary Table 2, Figure 3b ), which serves as a potent inhibitor of angiogenesis Lawler and Detmar, 2004) . These data are consistent with reports that show the stimulatory effects of BMPs on angiogenesis in different models (Liu et al., 2007; Araya et al., 2008; Heinke et al., 2008) . Our data, in addition to previously proposed mechanisms, suggest that BMP signaling may stimulate angiogenesis, at least in part, through the inhibition of the thrombospondin 2 expression.
The data presented here are also consistent with earlier observations showing the involvement of BMP signaling in the regulation of extracellular matrix remodeling and activity of matrix metalloproteinases (Rothhammer et al., 2008) . However, we show that BMP-4 treatment of keratinocytes and fibroblasts results in modulation of the expression of cell type-specific sets of proteolytic enzymes and their inhibitors. In keratinocytes, BMP-4 treatment results in the increase of expression of two members of the MMP family (MMP3 and MMP10), whereas in fibroblasts BMP-4 stimulates the expression of the ADAMS family of proteinases (ADAMTS5 and ADAM12; Supplementary Tables 2 and 3, Figure 3b and c). As the MMP and ADAMS subfamilies of metalloproteinases have different extracellular targets for cleavage and/or degradation (Malemud, 2006) , distinct effects of BMP-4 on their expression in keratinocytes and fibroblasts may reflect a distinct requirement of these molecules for modulating a tissue-specific microenvironment of these cells.
BMP-4 treatment also induced cell-type-specific changes in expression of the distinct components of the Wnt, NF-kB, IGF, FGF, Notch pathways suggesting the involvement of the BMP pathway in modulating regulatory signaling networks in keratinocytes and fibroblasts ( Supplementary Tables 2 and 3) . Interestingly, BMP-4 induced significant cell-type-specific change in BMP-6 expression in keratinocytes (Figure 3b ; Supplementary Table 2 ). These data suggested the existence of a positive regulatory loop in BMP signaling in this cell type in addition to negative feedback loops characterized earlier (Kretzschmar et al., 1997; Miyazono et al., 2005; Gazzerro and Canalis, 2006) .
Our data showing distinct responses to BMP-4 stimulation in keratinocytes and fibroblasts raise a question about mechanisms that determine cell type-dependent specificity in the effects of BMP signaling on the expression of its target genes. Most likely, such cell type-dependent contexts are determined by many factors, a combination of which results in the distinct effects of the BMP pathway on gene expression programs in keratinocytes versus fibroblasts. In particular, it has been shown that distinct BMP target genes may require different thresholds of the signal to trigger changes in their expression levels (Dosch et al., 1997) , and such signaling thresholds could be different in distinct cell types. Furthermore, the presence or absence of distinct coregulators of gene expression and/or distinct patterns of the promoter (s)/enhancer (s) of chromatin methylation/acetylation may also underlie cell-type-specific differences in the effects of BMP signaling on keratinocytes and fibroblasts (Misteli, 2007) . Another possibility explaining the differential regulation of gene expression by BMPs in distinct cell types could be the differences in their high-order chromatin structure and localization of the BMP target genes relative to distinct intra-nuclear functional compartments, such as euand heterochromatin, which may affect the accessibility of the targets for Smad transcription complexes (Lanctot et al., 2007) .
In summary, we report here what we believe to be the first comprehensive comparative microarray analysis of global changes in gene expression programs induced by BMP-4 in human epidermal keratinocytes and dermal fibroblasts. We show that the BMP-Smad pathway is active in both cell types and that its activation is accompanied by distinct changes in the transcriptomes of keratinocytes and fibroblasts, which are far more complex than the effects of BMPs on cell proliferation/differentiation described previously. Furthermore, our data suggest that the potential modulation of cell adhesion, extracellular matrix remodeling, cellular motility, metabolism, signaling, and transcription by BMP-4 in keratinocytes and fibroblasts is likely to be achieved by distinct sets of molecules specific for each cell type. Finally, these data provide an important platform for further delineating mechanisms that underlie the distinct effects of the BMP pathway on different cell populations in the skin and will be helpful in further establishing molecular signaling networks regulating skin homeostasis in health and disease.
MATERIALS AND METHODS

Cell culture experiments
Normal human epidermal keratinocytes and dermal fibroblasts were isolated from neonatal foreskin, as described previously (Gilchrest, 1979; Schindler et al., 2007) . Foreskin tissue was obtained using a protocol approved by the University of Boston Institutional Review Board in accordance with HIPAA and the Declaration of Helsinki Principles. Patient consent was not required. Keratinocytes were plated in serum-free keratinocyte medium (defined keratinocytes-SFM, Invitrogen, San Diego, CA) containing 0.15 mM calcium chloride and antibiotic-antimicotic mixture. Two days before the experiment, the cells were put in the medium containing 0.05 mM calcium chloride. Neonatal fibroblasts were grown in Dulbecco's Modification of Eagle's Medium (DMEM, Invitrogen), containing 10% fetal bovine serum (HyClone, Logan, UT) and antibiotic-antimicotic mixture (100 Â ; Invitrogen). Keratinocytes and fibroblasts were used in all the experiments at the third passage at 40-60% confluence. The cells were treated with 50 ng ml -1 recombinant human BMP-4 (R&D Systems, Minneapolis, MN) or diluent control. Fresh medium was added to the cells 4 hours before BMP-4 addition.
Western blot analysis
Western blot analysis of total cellular proteins was performed, as described earlier (Sharov et al., 2003 . All experiments were performed using at least three to four replicates. Antibody reaction was performed with rabbit monoclonal anti-phospho-p38 MAPK (Cell Signaling, Danvers, MA), rabbit monoclonal anti-phospho ERK1/2 (Cell Signaling), rabbit polyclonal anti-p38 MAPK (Sigma, St Louis, MO), rabbit polyclonal anti-ERK1/2 (Sigma), rabbit polyclonal anti-phospho JNK (Sigma), rabbit polyclonal anti-JNK (Sigma), mouse monoclonal anti-b-actin antibodies (Sigma), or rabbit polyclonal anti-phospho-SMAD1/5/8 antibodies (Millipore, Billerica, MA).
Microarray and RT-PCR analysis
Total RNA was isolated from neonatal keratinocytes and fibroblasts using Trizol Reagent (Invitrogen). All experiments were performed using at least three to four replicates, and RNA isolated from three to four experimental and control samples was pooled and processed for microarray analyses using one sample of pooled RNA per experimental and control group. All microarray analyses were performed at the Microarray Core Facility at the Boston University School of Medicine using the Human Genome U133 2.0 array (manufactured by Affymetrix), and the resulting data have been deposited in NCBI's Gene Expression Omnibus (Edgar et al., 2002) and are accessible through GEO Series accession number GSE16111 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE16111). After statistical analysis and initial filtering of the microarray data, changes in gene expression after BMP-4 treatment equal to or higher than 1.8-fold with at least one signal equal to or higher than 80 fluorescence units for the gene were considered significant. For semiquantitative and quantitative RT-PCR analysis, equal amounts of total RNA were used as a template for cDNA synthesis using the SuperScript III First-Strand Synthesis System and random primers (Invitrogen). PCR primers were designed using the Beacon Designer software (Premier Biosoft International, Palo Alto, CA) and are listed in Supplementary  Table 4 . Real-time PCR was performed using iCycler Thermal Cycler (Bio-Rad, Hercules, CA). Differences between samples and controls were calculated using the Gene Expression Macro program (Bio-Rad) based on the DDC t equitation method.
